key: cord-0267901-nj40hzp0 authors: Lenárt, Sára; Lenárt, Peter; Knopfová, Lucia; Kotasová, Hana; Pelková, Vendula; Sedláková, Veronika; Čan, Vladimír; Šmarda, Jan; Souček, Karel; Hampl, Aleš; Beneš, Petr title: TACSTD2 upregulation is an early reaction to lung infection date: 2021-06-30 journal: bioRxiv DOI: 10.1101/2021.06.29.450320 sha: 561f2e65fce79b849c0cc60770d991fc748ce5c2 doc_id: 267901 cord_uid: nj40hzp0 TACSTD2 encodes a transmembrane glycoprotein Trop2 commonly overexpressed in carcinomas. While the Trop2 protein was discovered already in 1981 and first antibody-drug conjugate targeting Trop2 were recently approved cancer therapy, the physiological role of Trop2 is still not fully understood. In this article, we show that TACSTD2/Trop2 expression is evolutionarily conserved in lungs of various vertebrates. By analysis of publicly available transcriptomic data we demonstrate that TACSTD2 level consistently increases in lungs infected with miscellaneous pathogens. Single cell and subpopulation based transcriptomic data revealed that the major source of TACSTD2 transcript are lung epithelial cells and their progenitors and that TACSTD2 is induced directly in lung epithelial cells following infection. This increase may represent a mechanism to maintain/restore epithelial barrier function and contribute to regeneration process in infected/damaged lungs. Trop2 is a transmembrane glycoprotein with yet unresolved physiological function, that is overexpressed in most carcinomas where it has been associated with cancer cell plasticity, tumor growth, metastasis and prognosis (1, 2) . It is encoded by the intronless TACSTD2 (tumor-associated calcium signal transducer 2) gene belonging to TACSTD gene family (3) . Genes of the TACSTD gene family are highly conserved across species; for instance, mouseTrop2 is 79.2% identical and 87.4% similar to human Trop2 (4, 5) . Trop2 was originally found on the surface of trophoblast cells (6) and has been subsequently identified on healthy epithelial cells of various other organs (7, 8) . Trop2 is also expressed during normal embryonal and fetal development in lungs (9, 10) , intestines (11) , stomach (12) , urinary bladder (13) , kidneys (14) , and cerebellum (15) , however, its function in healthy adult tissues remains unknown. In humans, congenital mutations of TACSTD2 cause a gelatinous drop-like corneal disease (GDLD), a rare autosomal recessive disease characterized by the development of bilateral corneal amyloidosis and eventually blindness (16) . Loss of the Trop2 function leads to impaired subcellular localizations of tight junction-related proteins and loss of barrier function of corneal epithelial cells resulting in passage of Lactoferrin to subepithelial region where it forms amyloid deposits (17) . Trop2 is also considered to be a stem/progenitor cell marker (11, 13, (18) (19) (20) (21) and several studies indicate that it might be associated with tissue remodeling and regeneration processes (12, 22, 23) . Surprisingly, the Tacstd2 null mice are fully viable, fertile, and without overt developmental abnormalities (24) . Lungs are vital organs inherently vulnerable to infection and injury due to constant exposure to pathogens, chemicals, and other air pollutants. The proper functions of epithelial barrier, immune system, and regenerative capacity of the lungs are thus crucial for restoring homeostasis following pathogen exposure or acute injury (25) . The importance of lung homeostasis maintenance is further highlighted by the fact that even before the rise of SARS-CoV-2 pandemic, respiratory diseases belonged to leading causes of death worldwide (26) . In this study, we use available expression datasets to test the hypothesis that the upregulation of TACSTD2 in the lungs is a physiological reaction to infection or injury, which both trigger an acute immune response (27) (28) (29) . In order to analyze TACSTD2/Trop2 expression in healthy lungs, several databases were searched. First, "TACSTD2" was searched in every species included in the Expression atlas database (30) (https://www.ebi.ac.uk/gxa/home, accessed on January 5, 2021). The results were filtered for baseline lung expression in each organism. From each study, information about expression level and the number of biological replicates was retrieved. The expression value was set to 0.5. "TACSTD2" was also searched in The Human Protein Atlas (31) (https://www.proteinatlas.org/, accessed on January 5, 2021) where the Tissue atlas was selected, and Lung was chosen to obtain RNA and protein expression data. "TACSTD2" was also searched in GTEx Portal (32) (https://www.gtexportal.org/home/, accessed on January 5, 2021, dbGaP accession number: phs000424.v8.p2). Even though, data we used from GTEx are also available in Expression Atlas and The Human Protein Atlas, the GTEx is the primary source and data in other databases are not always up to date. Therefore, when data were available from multiple sources, we used data from GTEx for analyses. Furthermore, "TACSTD2" was searched in Bgee database (33) (https://bgee.org/, accessed on January 5, 2021). Because Bgee database uses ArrayExpress, GEO, and GTEx -dbGAP as sources of raw data, and the same sources are also used by the Expression Atlas, TACSTD2 expression data from Bgee were used only for animals which TACSTD2 expression profile was not listed in Expression Atlas database, i.e., pig, chimpanzee, macaque, rabbit, and opossum (see Suplementary Data S1). To test the hypothesis that the overexpression of TACSTD2 in the lungs is a physiological reaction to infection or injury, we first analyzed differential TACSTD2 expression data for every species included in the Expression atlas database (30) (https://www.ebi.ac.uk/gxa/home, accessed on January 5, 2021). Results were filtered by choosing Infect or Injury in Experimental variables. Subsequently, only studies that met the following criteria were included: 1. The dataset must contain data from experiments with whole organisms, not cell lines. 2. The dataset provides information about lung transcriptome. 3. The dataset allows identification of differentially expressed genes following infection or injury. Additionally, the E-GEOD-33266 dataset, which was not found by the above-described approach as it did not contain the keyword "Infect" in its annotation, was identified by searching Expression Atlas COVID-19 Data Portal. In each particular study, Log2-fold change value was set to 0.0 so we could see even the small change of TACSTD2 expression. The adjusted p-value was set to 1, so we could see non-significant results as well. P-values were adjusted for multiple testing using the Benjamini and Hochberg false discovery rate (FDR) correction (34) . In order to pinpoint cell population(s) responsible for the increase of TACSTD2/Trop2 after infection in the lungs, we searched for datasets in Gene Expression Omnibus (GEO) (35) containing sorted cell populations from infected lungs or infected cell cultures in vitro. Expression values for TACSTD2/Tacstd2 from indicated datasets were retrieved, plotted and analyzed using GraphPad Prism v6.07 and shown in heat map using FGCZ Heatmap tool (http://fgcz-shiny.uzh.ch). The sample of human lungs was obtained from therapeutical surgery based on the written informed consent by the patient and approval of Ethics Committee of the University Hospital Brno (28-170621/EK). The specimens of pig, rat, mouse and human lungs were fixed with formalin, washed with PBS, dehydrated through series of alcohols (70%, 80%, and 96%) and embedded in paraffin blocks. Sections (4 μm thick) were dewaxed in xylene, hydrated through a graded series of alcohols (96%, 80%, and 70%), and rinsed in deionized water. After antigen retrieval in citrate buffer (pH 9.0, 12 min) at 98 ºC for 30 min., the slides were rinsed in tap and deionized water and washed with 3% H2O2 in PBS at room temperature (RT) for 10 min. To block endogenous peroxidase activity, the sections were treated with 10% fetal bovine serum for 30 min. The sections were incubated with the primary antibody against TROP2 (Abcam, ab227689, 1:100) for 1 h at RT. The slides were then washed three times in PBS and subsequently incubated with the secondary antibody (En Vision FLEX/HRP) for 20 min. After the last washing step, the slides were incubated in substrate solution (DAB), counterstained in hematoxylin, dehydrated with alcohols and xylene, and mounted. To test the hypothesis that upregulation of TACSTD2/Trop2 is a physiological reaction to lung tissue damage by infection or injury, we first verified that TACSTD2 is indeed expressed in healthy lungs. Analysis of available datasets shows overwhelming evidence that the TACTSD2 gene is expressed in lungs of all studied species ( Table 1) . This suggests that TACSTD2 has an evolutionarily conserved role in the function of lungs. A more detailed table is available in Supplementary data S1. Number of subjects To find which cell types produce TACSTD2 in the lungs, we searched the Human Protein Atlas. The highest expression has been detected in alveolar cells type I and II, club cells and ciliated cells but smaller amounts of TACSTD2 were also expressed in lung's immune cells such as macrophages, T-cells, and granulocytes ( Figure 1A) . Recently, single cell transcriptomic analysis revealed that out of 58 molecular cell types identified in human lungs, TACSTD2 is enriched in basal, differentiating basal, proliferating basal, proximal basal, goblet, alveolar epithelial type 1, platelets, and myeloid dendritic cells ( Figure 1B ) (36) . (39) . C) juvenile (2 weeks), adolescent (6 weeks), adult (21 weeks) and elderly (104 weeks) female and male rats (E-GEOD-53960) (38) . Four biological replicates were used for each sex and developmental stage. To confirm that Trop2 protein is expressed in lungs of various organisms we performed IHC analysis in paraffin sections of human, mouse and pig lung tissues. In human lungs, Trop2 staining was observed in membranes of airway and alveolar epithelial cells while only basolateral parts of airway epithelium was Trop2 positive in mouse and pig lungs (Figure 3, Supplementary Figure S1 ). These data confirms that Trop2 is produced by lung epithelial cells but also point to differences in its expression pattern in lungs of selected vertebrates. Next, to analyze TACSTD2 expression in response to lung damage, we searched the Expression Atlas database for differential expression in lungs after infection or injury. Eleven differential expression datasets analyzed the levels of Tacstd2 early after infection (1-7 days) , and all of them showed a significant upregulation of Tacstd2 in infected mouse lungs ( Table 2) . This increase was observed in both males and females, 9 different mouse strains, at various ages (8-20 weeks) , and with various infectious agents. Datasets containing information about the dynamics of this process showed that in the case of SARS coronavirus MA15, the levels of Tacstd2 peaked two days post-infection and then started to decrease, indicating that the upregulation of Tacstd2 is an early reaction to infection (Table 2, Figure 4 ). After infection with the influenza A virus, Tacstd2 levels peaked on the fourth day, but the increase rate was reduced after the second day confirming that Tacstd2 elevation is an early response ( Table 2) . Particularly intriguing is the E-GEOD-33266 dataset, where various doses of SARS coronavirus were used for infecting mice. Analysis of this dataset not only confirmed that Tacstd2 levels were highest two days after SARS coronavirus infection regardless of the infection dose but also showed that a higher dose of the virus induced higher upregulation of TACSTD2 (Table 2) . Interestingly, two datasets that tested Tacstd2 expression after a longer time ( Table S1 ). TACSTD2 levels after an injury did not fulfill inclusion criteria as it studied transcripts in blood and not lungs. However, it is interesting to note that it showed significantly upregulated TACSTD2 in leukocytes after burn injury in both children (60 subjects) and adults (57 subjects). More details are available in Table S2 in Supplementary data. Interestingly, levels of TACSTD2 were higher in the middle stage (11- datasets for information about TACSTD2 expression after infection in specific cell types. Datasets examining expression after infecting mice with influenza virus X31 (42) (GSE148709, Figure 5A ), and Streptococcus pneumoniae (43) (GSE71623, Figure 5B ) showed that Tacstd2 is significantly upregulated in sorted LECs when compared to uninfected cells. LECs were sorted according to their EpCAM + CD31 -CD45 -(GSE148709) or EpCAM + CD45 -(GSE71623) expression. Upregulation of Tacstd2 was detected also in LECs of influenza virus X31 infected Ifnlr1 -/mice. were isolated and the transcriptome was analyzed by high throughput sequencing. Interestingly, after infection with influenza virus, Tacstd2 expression was increased in club cells and slightly in AECs and eosinophils, but decreased in neutrophils ( Figure 6A ). According to these data neutrophils of uninfected lungs have the highest basal expression of Tacstd2. (45) . To further confirm the effect of infection on TACSTD2 upregulation in lung cells we searched for datasets examining TACSTD2 expression in LECs in vitro. TACSTD2 was upregulated in human alveolar type II cell organoids infected with SARS coronavirus 2 (44) (GSE152586, Figure 6B ) as well as in well-differentiated primary human bronchial LECs infected with various influenza A isolates (45) (GDS4855, Figure 6C ) when compared to uninfected cells. These data confirm that LECs contribute to the increase of TACSTD2 levels in lungs following infection. Overall, overexpression of TACSTD2 is an early event in the lungs challenged with various infection agents. Although increased immune cell infiltration may be partially responsible for this increase, transcriptomic studies in epithelial cells sorted from lungs of infected mice and in vitro infected LECs clearly proved direct upregulation of TACSTD2. In this article, we have analysed available transcriptomic data to decipher the function of TACSTD2 in lung tissue. Our findings may be summarized as follows. First, we have presented strong evidence that TACSTD2 is expressed in healthy lungs of various species suggesting its evolutionarily conserved role. Second and most importantly, our analyses have shown that Tacstd2 (50, 51) . Decreased expression and altered localization of these proteins were also observed in the corneas of GDLD patients (50) . Moreover, forced expression of Trop2 can at least partially stabilize claudins and restore epithelial barrier in mouse model of congenital tufting enteropathy (52) . Therefore, a possible explanation of TACSTD2 upregulation following infection is that it represents a mechanism that helps maintain/restore the airway epithelial barrier function. It has been shown that Trop2 is expressed in many organs during embryonal development, including lungs (9) (10) (11) (12) (13) (14) (15) . It usually marks progenitor cells with high proliferation/self-renewal capacity. In fetal ovine and rat lungs, Trop2 expression positively correlates with proliferation rate (10) . The cells exhibiting high Trop2 expression significantly contribute to tissue regeneration in stomach and endometrium (12, 22) . In stomach, transcriptome analysis further indicated that Trop2 + cells involved in epithelial regeneration overexpress genes that are part of a fetal developmental program (12) . We therefore hypothesize that the upregulation of Trop2 in (sub)population of LECs/progenitor cells may also enhance their proliferative/pro-regenerative capacity and contribute to healing process in infected lungs. It should be noted, however, that the long term Trop2 overexpression associated with inflammation may result in hyperplasia of airway epithelium as observed in lungs of COPD patients (41) . Although both proteins interact with tight junction proteins (50, 69) and participate in maintenance of epithelial barrier (51, 70, 71) , recent study in EpCAM null mice with forced expression of Trop2 revealed that the function of both proteins is similar but not equivalent (52) . Interestingly, we did not find a similar pattern of deregulation of TACSTD1 expression in lungs after infection as observed for TACSTD2 (Supplementary Table S3 ). This finding highlights an important distinction in regulation of expression of both genes and indicates another possible difference in their function. Taken together, using available transcriptomic datasets we demonstrate that TACSTD2 expression is evolutionarily conserved in the lungs of vertebrates and that the major source of TACSTD2 transcript are lung epithelial cells and their progenitors. We found that lung levels of TACSTD2 consistently increase as an early reaction to infection with various respiratory pathogens. Although this increase may represent a mechanism to maintain/restore epithelial barrier function and to mark pro-regenerative activation of progenitor cells in infected lungs, further studies are needed to clarify the exact role of the Trop2 protein and its signaling during course of lung infections and healing process. Trop2: Jack of All Trades, Master of None. Cancers Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733 Retroposition in a family of carcinoma-associated antigen genes Cloning of the murine TROP2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2 Human trophoblast cell-surface antigens defined by monoclonal antibodies Expression of Trop2 Cell Surface Glycoprotein in Normal and Tumor Tissues Upregulation of Trop-2 quantitatively stimulates human cancer growth Gene expression profiling during increased fetal lung expansion identifies genes likely to regulate development of the distal airways The oncogene Trop2 regulates fetal lung cell proliferation Identification of Lgr5-independent spheroid-generating progenitors of the mouse fetal intestinal epithelium. Cell Rep Trop2 marks transient gastric fetal epithelium and adult regenerating cells after epithelial damage. Dev Camb Engl Identification of potential bladder progenitor cells in the trigone TROP2 expressed in the trunk of the ureteric duct regulates branching morphogenesis during kidney development Intrauterine Growth Restriction Alters the Postnatal Development of the Rat Cerebellum Identification of the gene responsible for gelatinous drop-like corneal dystrophy Phenotypic Investigation of Cell Junction-Related Proteins in Gelatinous Drop-Like Corneal Dystrophy A human liver cell atlas reveals heterogeneity and epithelial progenitors Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver Trop2 regulates the proliferation and differentiation of murine compact-bone derived MSCs Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium Trop2 Guarantees Cardioprotective Effects of Cortical Bone-Derived Stem Cells on Myocardial Ischemia/Reperfusion Injury Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma Acute lung injury and bacterial infection Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study Immune response to traumatic injury: harmony and discordance of immune system homeostasis Trauma equals danger--damage control by the immune system Innate immune responses to trauma Expression Atlas update: from tissues to single cells Proteomics. Tissue-based map of the human proteome The Genotype-Tissue Expression (GTEx) project The Bgee suite: integrated curated expression atlas and comparative transcriptomics in animals Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing NCBI GEO: archive for functional genomics data sets--update A molecular cell atlas of the human lung from single-cell RNA sequencing A cellular census of human lungs identifies novel cell states in health and in asthma A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics Persistent activation of an innate immune axis translates respiratory viral infection into chronic lung disease Increased expression of TROP2 in airway basal cells potentially contributes to airway remodeling in chronic obstructive pulmonary disease Type I and III interferons disrupt lung epithelial repair during recovery from viral infection Epithelial Cell-Derived Secreted and Transmembrane 1a Signals to Activated Neutrophils during Pneumococcal Pneumonia Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction Early host responses of seasonal and pandemic influenza A viruses in primary well-differentiated human lung epithelial cells New Insights into Airway Epithelial Barrier Function in Health and Disease The Type III Toxins of Pseudomonas aeruginosa Disrupt Epithelial Barrier Function Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions Airway tight junctions as targets of viral infections. Tissue Barriers Tumor-Associated Calcium Signal Transducer 2 Is Required for the Proper Subcellular Localization of Claudin 1 and 7: Implications in the Pathogenesis of Gelatinous Drop-Like Corneal Dystrophy A New in Vitro Model of GDLD by Knocking Out TACSTD2 and Its Paralogous Gene EpCAM in Human Corneal Epithelial Cells Amelioration of Congenital Tufting Enteropathy in EpCAM (TROP1)-Deficient Mice via Heterotopic Expression of TROP2 in Intestinal Epithelial Cells. Cells Trop-2 Induces Tumor Growth Through AKT and Determines Sensitivity to AKT Inhibitors TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT TROP2 promotes cell proliferation and migration in osteosarcoma through PI3K/AKT signaling Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway Targeting the phosphoinositide-3-kinase/protein kinase B pathway in airway innate immunity The p110δ isoforme of phosphatidylinositol 3-kinase plays an important role in host defense against chlamydial lung infection through influencing CD4+ T-cell function Lung Surfactant Lipids Provide Immune Protection Against Haemophilus influenzae Respiratory Infection. Front Immunol Caveolin-1 plays a critical role in host immunity against Klebsiella pneumoniae by regulating STAT5 and Akt activity Inhibition of the PI3K/AKT Signaling Pathway or Overexpression of Beclin1 Blocks Reinfection of Streptococcus pneumoniae After Infection of Influenza A Virus in Severe Community-Acquired Pneumonia Host cellular signaling induced by influenza virus. Sci China Life Sci Tight Junctions Go Viral! Viruses Claudins in viral infection: From entry to spread. Pflugers Arch Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2 Shedding light on the EpCAM: An overview Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions Mutation of EpCAM leads to intestinal barrier and ion transport dysfunction Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins